91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In this DDW article, discover key findings of an 91黑料 survey focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities.
-
91黑料 survey shows pharma's enthusiasm for multi-indication obesity trials is outpacing trial design readiness.
-
In this article, 91黑料 experts explore the connection of obesity and inflammation, the current treatment landscape and future treatment directions.
-
The absence of sufficient and accessible diagnostics for metabolic dysfunction-associated steatohepatitis (MASH) studies can complicate trials and impair clinical study conduct, as diagnostics are essential for disease detection, confirmation, and monitoring.
-
Explore the evolving obesity clinical trials landscape and the role of decentralisation and new technologies in this recent CTA article.
-
91黑料 experts, Jack Martin and Simon Bruce share insights with BioSpectrum Asia on emerging trends in obesity treatment and the future implications for pharma.
-
In this article, 91黑料 experts Alan Baldridge and Heather Peterson discuss the prevalence of paediatric obesity and assess clinical trials of its treatments.
-
In this article, CON’s Jack Martin discusses the direction obesity drug research is heading, and the challenges faced by researchers.
-
In this article, 91黑料's Jack Martin explores the impact of comorbidities on obesity therapeutic development including strategic and innovative approaches to therapeutic development and clinical trials design.
-
Recent advancements in obesity treatments have spotlighted the field for healthcare providers and developers. In this article from Drug Discovery World, 91黑料 experts share insights on the clinical trials landscape for obesity and why patient centricity is key to overcoming common challenges in the sector.
